Bio-Techne (TECH) total liabilities

Total liabilities · fiscal 2026
$478.51M

Bio-Techne (TECH) had total liabilities of $478.51M at the end of fiscal 2026 (June 30, 2026). That is 25.1% lower than the $639.06M of fiscal 2025. Figures as of 19 Nov 2026, 00:02 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2026
$478.51M
Change on fiscal 2025
−25.1%
Highest on record
$672.18Mfiscal 2023
Lowest on record
$478.51Mfiscal 2026
Fiscal years on record
42023–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Bio-Techne total liabilities, in more detail

Across the 4 fiscal years on record (2023–2026), the highest was $672.18M in fiscal 2023 and the lowest $478.51M in fiscal 2026.

History · 4 fiscal years

Total liabilities by fiscal year

Bio-Techne total liabilities, year by year

Bio-Techne (TECH) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2026$478.51M 25.1% down
2025$639.06M 0.6% up
2024$635.02M 5.5% down
2023$672.18M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of Bio-Techne and comparable companies
CompanyTotal liabilitiesFiscal year
DaVita DVA$16.32B2025
Halozyme Therapeutics HALO$2.48B2025
Universal Health Services UHS$8.12B2025
Repligen RGEN$843.57M2025
Bio-Techne TECH$478.51M2026
BioMarin Pharmaceutical BMRN$1.51B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TECH

Bio-Techne, figure by figure

Bio-Techne (TECH) overview: price, valuation and scorecardAll health care companies by market value

Bio-Techne total liabilities: questions and answers

How large are Bio-Techne's total liabilities?

Bio-Techne (TECH) had total liabilities of $478.51M at the end of fiscal 2026 (June 30, 2026). That is 25.1% lower than the $639.06M of fiscal 2025.

What are the highest and lowest total liabilities figures on record for Bio-Techne?

Across the 4 fiscal years on record (2023–2026), the highest was $672.18M in fiscal 2023 and the lowest $478.51M in fiscal 2026.

How is Bio-Techne's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Bio-Techne it is on record here for 4 fiscal years, 2023 to 2026.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bio-Techne (TECH) total liabilities”, data as of 19 November 2026. https://funkfolio.com/stock/TECH/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.